Minimizing the immunogenicity of protein therapeutics

Author： Chirino A.J.   Ary M.L.   Marshall S.A.  

Publisher： Elsevier

ISSN： 1359-6446

Source： Drug Discovery Today, Vol.9, Iss.2, 2004-01, pp. : 82-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reducing the Immunogenicity of Protein Therapeutics

By  

Current Drug Targets, Vol. 10, Iss. 2, 2009-02 ,pp. : 131-139

Bentham Science Publishers

Access to resources Recommend Favorite

Immunogenicity of therapeutics: a matter of efficacy and safety

By Nechansky Andreas   Kircheis Ralf  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 11, 2010-11 ,pp. : 1067-1079

Informa Healthcare

Access to resources Recommend Favorite

Rational engineering of protein therapeutics

By  

Inpharma, Vol. 1, Iss. 1383-1384, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Inhalation Delivery of Protein Therapeutics

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 12, Iss. 2, 2013-04 ,pp. : 81-87

Bentham Science Publishers

Access to resources Recommend Favorite

Start Small and Stay Small: Minimizing Attrition in the Clinic with a Focus on CNS Therapeutics

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 18, 2009-12 ,pp. : 1688-1704

Bentham Science Publishers

Access to resources Recommend Favorite